Nivolumab in Previously Untreated Melanoma without BRAF Mutation

Overview of attention for article published in New England Journal of Medicine, November 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 12 public wall posts from 8 users.

http://www.nejm.org/doi/full/10.1056/NEJMoa1412082#t=article

http://genevadermatology.ch/melanoma-a-new-targeted-therapy-anti-pd1-nivolumab/

Nivolumab in previously untreated melanoma without BRAF mutation. Robert C. et al. N Engl J Med. 2015 Jan 22;372(4):320-30. doi…

Melanoma: a More Recent Targeted Therapy (Anti-PD1, Nivolumab; Opdivo)

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity, including 8 additional Facebook posts.